Overview

Psilocybin-Assisted Randomized Therapy

Status:
NOT_YET_RECRUITING
Trial end date:
2027-03-01
Target enrollment:
Participant gender:
Summary
This pilot study will examine the safety, tolerability, acceptability, and efficacy of combination psilocybin + psychotherapy to decrease PTSD symptoms. Participants will be randomized into two different treatment groups, allowing the investigators to directly compare PE augmented with psilocybin and psilocybin-assisted psychotherapy.
Phase:
PHASE2
Details
Lead Sponsor:
Emory University
Collaborator:
Georgia Department of Veterans Services
Treatments:
Palliative Care
Psilocybin